Shares of The Chemours Company (NYSE:CC – Get Free Report) have earned an average rating of “Hold” from the eight ratings firms that are covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $30.89.
CC has been the topic of a number of analyst reports. BMO Capital Markets upgraded shares of Chemours from an “underperform” rating to an “outperform” rating and lifted their target price for the stock from $19.00 to $34.00 in a research report on Tuesday, April 9th. Barclays lowered their target price on Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. Finally, UBS Group raised their price target on Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 2nd.
Get Our Latest Stock Analysis on Chemours
Hedge Funds Weigh In On Chemours
Chemours Price Performance
Shares of Chemours stock opened at $26.42 on Tuesday. The business’s 50-day moving average price is $26.80 and its 200-day moving average price is $27.80. The firm has a market capitalization of $3.93 billion, a PE ratio of -17.05 and a beta of 2.00. Chemours has a 12 month low of $15.10 and a 12 month high of $39.05. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40.
Chemours (NYSE:CC – Get Free Report) last issued its quarterly earnings results on Wednesday, March 27th. The specialty chemicals company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The business had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. Sell-side analysts forecast that Chemours will post 2.23 EPS for the current fiscal year.
Chemours Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.79%. The ex-dividend date was Friday, February 23rd. Chemours’s dividend payout ratio (DPR) is currently -64.52%.
Chemours Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Recommended Stories
- Five stocks we like better than Chemours
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Merger or Not, Albertson’s Companies is a Good Buy
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.